When CRISPR/Cas9 gene editing firm Editas recently went public, it drew in some $94 million, but Technology Review writes that the company's "ambitions rest on shaky foundations."
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.
Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.
Researchers are using gene editing to develop more robust livestock and crops, AFP reports.
Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.